Glucocorticoid Dose Is Progressively Reduced in Patients with RA Receiving Sarilumab: Results from the Open-Label EXTEND Study Fleischmann, R., Selmi, C., Gonzalez-Gay, M., van Hoogstraten, H., Hagino, O., Rajput, T., St John, G., Buttgereit, F., Genovese, M. WILEY. 2019

View details for Web of Science ID 000507466902237